These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24104412)

  • 1. Haematopoietic stem cell transplantation for acquired aplastic anaemia.
    Young ME; Potter V; Kulasekararaj AG; Mufti GJ; Marsh JC
    Curr Opin Hematol; 2013 Nov; 20(6):515-20. PubMed ID: 24104412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.
    Peinemann F; Bartel C; Grouven U
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006407. PubMed ID: 23881658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Case for Upfront HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation as a Curative Option for Adult Acquired Severe Aplastic Anemia.
    Marsh JCW; Risitano AM; Mufti GJ
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):e277-e284. PubMed ID: 31129354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia.
    Lu Y; Sun RJ; Zhao YL; Xiong M; Cao XY; Zhang JP; Wei ZJ; Zhou JR; Liu DY; Lu DP
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1881-1887. PubMed ID: 29772350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
    Dufour C; Veys P; Carraro E; Bhatnagar N; Pillon M; Wynn R; Gibson B; Vora AJ; Steward CG; Ewins AM; Hough RE; de la Fuente J; Velangi M; Amrolia PJ; Skinner R; Bacigalupo A; Risitano AM; Socie G; Peffault de Latour R; Passweg J; Rovo A; Tichelli A; Schrezenmeier H; Hochsmann B; Bader P; van Biezen A; Aljurf MD; Kulasekararaj A; Marsh JC; Samarasinghe S
    Br J Haematol; 2015 Nov; 171(4):585-94. PubMed ID: 26223288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matched sibling versus matched unrelated allogeneic hematopoietic stem cell transplantation in children with severe acquired aplastic anemia: experience of the polish pediatric group for hematopoietic stem cell transplantation.
    Szpecht D; Gorczyńska E; Kałwak K; Owoc-Lempach J; Choma M; Styczyński J; Goździk J; Dłużniewska A; Wysocki M; Kowalczyk JR; Chybicka A; Pieczonka A; Wachowiak J
    Arch Immunol Ther Exp (Warsz); 2012 Jun; 60(3):225-33. PubMed ID: 22527354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies.
    Iftikhar R; Chaudhry QUN; Anwer F; Neupane K; Rafae A; Mahmood SK; Ghafoor T; Shahbaz N; Khan MA; Khattak TA; Shamshad GU; Rehman J; Farhan M; Khan M; Ansar I; Ashraf R; Marsh J; Satti TM; Ahmed P
    Blood Rev; 2021 May; 47():100772. PubMed ID: 33187812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unrelated donor search and unrelated donor transplantation in the adult aplastic anaemia patient aged 18-40 years without an HLA-identical sibling and failing immunosuppression.
    Bacigalupo A; Marsh JC
    Bone Marrow Transplant; 2013 Feb; 48(2):198-200. PubMed ID: 23178545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Outcomes of Frontline Immunosuppressive Therapy and Frontline Haploidentical Hematopoietic Stem Cell Transplantation for Children with Severe Aplastic Anemia Who Lack an HLA-Matched Sibling Donor.
    Yang S; Yuan X; Ma R; Jiang L; Guo J; Zang Y; Shi J; Yang J; Lei P; Liu Z; Zhang Y; Zhu Z
    Biol Blood Marrow Transplant; 2019 May; 25(5):975-980. PubMed ID: 30658223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aplastic anemia: therapeutic updates in immunosuppression and transplantation.
    Scheinberg P
    Hematology Am Soc Hematol Educ Program; 2012; 2012():292-300. PubMed ID: 23233595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontline Therapy Options for Adults With Newly Diagnosed Severe Aplastic Anemia: Intensive immunosuppressive Therapy Plus Eltrombopag or Matched Sibling Donor Hematopoietic Stem Cell Transplantation?
    Huang LF; Li L; Jia JS; Yang Y; Lin SY; Meng FK; Zhang DH; He GS
    Transplant Cell Ther; 2022 Sep; 28(9):586.e1-586.e7. PubMed ID: 35609866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: a United Kingdom multicentre retrospective experience.
    Samarasinghe S; Steward C; Hiwarkar P; Saif MA; Hough R; Webb D; Norton A; Lawson S; Qureshi A; Connor P; Carey P; Skinner R; Vora A; Pelidis M; Gibson B; Stewart G; Keogh S; Goulden N; Bonney D; Stubbs M; Amrolia P; Rao K; Meyer S; Wynn R; Veys P
    Br J Haematol; 2012 May; 157(3):339-46. PubMed ID: 22372373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell transplantation for acquired aplastic anemia.
    Georges GE; Storb R
    Curr Opin Hematol; 2016 Nov; 23(6):495-500. PubMed ID: 27607445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of frontline treatment with intensive immunosuppression therapy and HLA-haploidentical hematopoietic stem cell transplantation for young patients with severe aplastic anemia - A meta analysis.
    Geng C; Liu X; Chen M; Yang C; Han B
    Leuk Res; 2020 Jan; 88():106266. PubMed ID: 31743865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation.
    Marsh JC; Pearce RM; Koh MB; Lim Z; Pagliuca A; Mufti GJ; Perry J; Snowden JA; Vora AJ; Wynn RT; Russell N; Gibson B; Gilleece M; Milligan D; Veys P; Samarasinghe S; McMullin M; Kirkland K; Cook G;
    Bone Marrow Transplant; 2014 Jan; 49(1):42-8. PubMed ID: 23912664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic stem cell transplantation for children with acquired severe aplastic anaemia: a retrospective study by the Viva-Asia Blood and Marrow Transplantation Group.
    Chen J; Lee V; Luo CJ; Chiang AK; Hongeng S; Tan PL; Tan AM; Sanpakit K; Li CF; Lee AC; Chua HC; Okamoto Y
    Br J Haematol; 2013 Aug; 162(3):383-91. PubMed ID: 23735201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic Hematopoietic Stem Cell Transplant for Severe Aplastic Anemia: Current State and Future Directions.
    Sun Q; Wu B; Zhu Z; Sun C; Xu J; Long H; Huang Y; Xu J; Song C
    Curr Stem Cell Res Ther; 2018; 13(5):350-355. PubMed ID: 28245775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.
    Maury S; Balère-Appert ML; Chir Z; Boiron JM; Galambrun C; Yakouben K; Bordigoni P; Marie-Cardine A; Milpied N; Kanold J; Maillard N; Socié G;
    Haematologica; 2007 May; 92(5):589-96. PubMed ID: 17488681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing conditioning regimen with low-dose irradiation or busulfan enables the outcome of transplantation from a 6-7/8 HLA-matched donor comparable to that from an 8/8 HLA-matched unrelated donor in severe aplastic anemia patients under 40 years.
    Qin X; Zhu YP; Luo CJ; Zhou M; Huang K; Chen C; Zhang WP; Sun Y; Luo RM; Tang XF; Yang T; Song XM; Hu SY; Sun ZM; Hu J; Wang SQ; Chen J
    Ann Hematol; 2021 Sep; 100(9):2363-2373. PubMed ID: 33988738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.